Literature DB >> 15790506

Differential signalling during B-cell maturation.

Margaret M Harnett1, Elad Katz, Catriona A Ford.   

Abstract

The molecular mechanism by which the antigen receptors (BCR) on B cells can elicit differential maturation state-specific responses is one of the central problems in B-cell differentiation yet to be resolved. Indeed, many of the early signalling events detected following BCR ligation, such as activation of protein tyrosine kinases (PTK), phospholipase C (PLC), phosphoinositide-3-kinase (PI 3K), protein kinase C (PKC) and the RasMAPK (mitogen activating protein kinase) signalling cascades are observed throughout B-cell maturation. However, it is becoming clear that the differential functional responses of these BCR-coupled signals observed during B-cell maturation are dependent on a number of parameters including signal strength and duration, subcellular localisation of the signal, maturation-restricted expression of downstream signalling effector elements/isoforms and modulation of signal by co-receptors. Thus, the combined signature of BCR signalling is likely to dictate the functional response and act as a developmental checkpoint for B-cell maturation.

Mesh:

Substances:

Year:  2004        PMID: 15790506     DOI: 10.1016/j.imlet.2004.11.002

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  5 in total

1.  Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Authors:  Heather MacLeod; Navneet Bhasin; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

2.  Glycosylphosphatidylinositol-anchored arginine-specific ADP-ribosyltransferase7.1 (Art7.1) on chicken B cells: the possible role of Art7 in B cell receptor signalling and proliferation.

Authors:  Masaharu Terashima; Mai Takahashi; Makoto Shimoyama; Yoshinori Tanigawa; Takeshi Urano; Mikako Tsuchiya
Journal:  Mol Cell Biochem       Date:  2008-08-12       Impact factor: 3.396

3.  Simulation of the Dynamics of Primary Immunodeficiencies in B Cells.

Authors:  Gabriel Ndipagbornchi Teku; Mauno Vihinen
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

Review 4.  Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis.

Authors:  Verica Paunovic; Margaret M Harnett
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

5.  Defective Bcl-2 expression in memory B cells from common variable immunodeficiency patients.

Authors:  L Del Pino Molina; J M Torres Canizales; O Pernía; R Rodríguez Pena; I Ibanez de Caceres; E López Granados
Journal:  Clin Exp Immunol       Date:  2020-10-08       Impact factor: 5.732

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.